-
October 30, 2023
- News & Events
- Papers & Conferences
At CTAD 2023 (Clinical Trials on Alzheimer’s Disease; Boston, USA, October 24-27), Professor Shimokawa presented the protocol of the LIPUS-Brain pivotal study (LIPUS-AD).
-
October 26, 2023
- News & Events
- Papers & Conferences
Prof. Shimokawa gave an invited lecture at Harvard University Massachusetts General Hospital on microcirculatory disorders (heart and brain) and the development of LIPUS treatment as an advanced therapy.
-
October 4, 2023
- News & Events
We Will Exhibit at the Luncheon Seminar and Corporate Exhibition at the 42nd Annual Meeting of the Japanese Society for Dementia Research
-
September 20, 2023
- News & Events
Notice of Allowance Issued “LIPUS-Brain”, a Medical Device for the Treatment of Early Alzheimer’s Disease
-
September 6, 2023
- News & Events
New page added for pivotal clinical trial for patients with early-stage Alzheimer’s disease.
-
September 5, 2023
- News & Events
LIPUS-Brain pivotal trial for patients with early-stage Alzheimer’s disease has been initiated
-
September 5, 2023
- News & Events
Announcement of Corporate Office Relocation
-
July 12, 2023
- News & Events
- Papers & Conferences
Prof. Shimokawa, Founder, Chairman & CMO, and Yoshikawa , Head of R&D, will speak at the 1st Tokyo Metropolitan Industrial Technology Research Institute Medical Engineering Collaboration Seminar 2023.
-
July 12, 2023
- News & Events
- Papers & Conferences
A paper of Professor Hiroaki Shimokawa, Founder, Chairman & CMO of SWI, has been published online in the journal PLOS ONE.
-
June 20, 2023
- News & Events
- Papers & Conferences
An abstract reporting the protocol details of the LIPUS-Heart pivotal trial has been accepted for this year’s CTAD (Clinical Trials on Alzheimer’s Disease, October 24-27, Boston).